fbpx Revisions for Clorochina e remdesivir, i dati sui farmaci per SARS-CoV-2 | Science in the net

Revisions for Clorochina e remdesivir, i dati sui farmaci per SARS-CoV-2

Primary tabs

Revision Operations
15 February, 2023 - 10:17 by Sergio Cima
This is the published revision.
14 March, 2020 - 16:59 by Amministratore

prossimo articolo

The embarrassing Covid

There's a certain discomfort in having to talk about Covid-19 again, as demanded by the increase in cases that is also recorded in Italy. The reason, writes epidemiologist Stefania Salmaso, might perhaps be identified in the lack of a transparent process that allows understanding on what basis the health authority formulates recommendations, leading to reliance on pundits.

Image credits: visuals/Unsplash

“An embarrassing Covid-19”: It could be the title of a short story by Calvino or a rhyme by Rodari, but it's what we're witnessing these days. The increasing frequency of SARS-CoV-2 infections in various areas of the world, including Italy, has forced mainstream media to address it again. However, it's often discussed with a sort of embarrassment and only for the sake of reporting. When discussing possible countermeasures, the discomfort becomes even more apparent.